Skip to main content
. 2021 Sep 8;13:720715. doi: 10.3389/fnagi.2021.720715

TABLE 5.

Pharmacological treatment for VaD and their effects.

Drug classes Drugs Effects
Cholinesterase inhibitors Donepezil, Galantamine, Rivastigmine Safe and effective in reducing the progression of VaD in addressing the behavioral problems.
Vasodilators Niacin (nicotinic acid), Cyclandelate, Papaverine, Isoxsuprine, Cinnarizine, Buflomedil, Naftidrofuryl, Ergoloid mesylates, Acetazolamide Have shown to be less effective in treating VaD compared to cortical dementias like Alzheimer’s.
Calcium channel blockers Nimodipine Moderately effective for short term in treating cerebrovascular disease and other types of dementia.
N-methyl-D-aspartate (NMDA) antagonists Nicardipine Improvement of cognitive deterioration
NMDA antagonists Memantine Improve cognition consistently across different cognitive scales, with at least no deterioration in global functioning and behavior.
Nootropic agents Piracetam, Nicergoline, Oxiracetam Citicoline, Pentoxifylline have beneficial effects for patients with dementia in prolonging their survival.
Antiplatelet agents Aspirin, Triflusal, Ginkgo biloba Reduce/prevent the occurrence of stroke.